decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
National_Coverage_Determinations_Manual / CHEMICALAVERSION_THERAPY_FOR_TREATMENT_OF_ALCOHOLISM
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a Medicare national coverage determination related to chemical aversion therapy for alcoholism. It is intended for coders, billers, compliance staff, and clinical documentation reviewers who need to understand the coverage framework, documentation expectations, and the general clinical context described in the policy. The article focuses on broad coverage criteria, inpatient versus outpatient setting considerations, and the role of physician certification and medical review.
Why This Topic Matters
It helps readers determine whether the policy applies to a patient encounter and what general documentation and care-setting issues are relevant under Medicare coverage guidance.
Article Sections
-
Chemical Aversion Therapy for Treatment of Alcoholism
Introduces the therapy, its clinical purpose, and the general context for Medicare coverage. It also discusses the setting of care and the role of medical necessity review.
What You Will Learn
- The overall Medicare coverage context for chemical aversion therapy in alcoholism treatment
- How the policy addresses patient appropriateness and physician certification
- What the article says at a high level about inpatient and outpatient care settings
- Which organizations and review processes are mentioned in connection with medical necessity determinations
Who Should Read This
- Medical coders
- Billing specialists
- Compliance professionals
- Utilization review staff
- Clinical documentation reviewers
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com